Date
- Thursday, 05 March 2015
Location
- European Medicines Agency, Amsterdam, the Netherlands
This is an information session on biosimilars with representatives from patients', consumers' and healthcare professionals' organisations. In addition to providing an overview to PCWP and HCPWP members of the science behind biosimilars and how they are evaluated by regulators, the session will explore how to bridge the scientific evaluation with clinical reality and public acceptability of biosimilars and discuss the role of communication in promoting better understanding of biosimilars. Registration by invitation only.